[1]
L. Wang, Z. Teng, and D. Cai, “Retraction: Monotherapy with meropenem versus combination therapy of ceftazidime plus amikacin for empirical treatment of cancer patients with Febrile Neutropenic (FN): systematic review and meta-analysis”, Eur J Oncol Env Hea, vol. 21, no. 3, Dec. 2016, Accessed: Jan. 20, 2026. [Online]. Available: https://www.mattioli1885journals.com/index.php/EJOEH/article/view/6060